Selecting the most appropriate time points to profile in high-throughput studies

  1. Michael Kleyman
  2. Emre Sefer
  3. Teodora Nicola
  4. Celia Espinoza
  5. Divya Chhabra
  6. James S Hagood
  7. Naftali Kaminski
  8. Namasivayam Ambalavanan
  9. Ziv Bar-Joseph  Is a corresponding author
  1. Carnegie Mellon University, United States
  2. University of Alabama at Birmingham, United States
  3. University of California, San Diego, United States
  4. Yale University, United States

Abstract

Biological systems are increasingly being studied by high throughput profiling of molecular data over time. Determining the set of time points to sample in studies that profile several different types of molecular data is still challenging. Here we present the Time Point Selection (TPS) method that solves this combinatorial problem in a principled and practical way. TPS utilizes expression data from a small set of genes sampled at a high rate. As we show by applying TPS to study mouse lung development, the points selected by TPS can be used to reconstruct an accurate representation for the expression values of the non selected points. Further, even though the selection is only based on gene expression, these points are also appropriate for representing a much larger set of protein, miRNA and DNA methylation changes over time. TPS can thus serve as a key design strategy for high throughput time series experiments.

Data availability

The following data sets were generated

Article and author information

Author details

  1. Michael Kleyman

    Machine Learning and Computational Biology, School of Computer Science, Carnegie Mellon University, Pittsburgh, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Emre Sefer

    Machine Learning and Computational Biology, School of Computer Science, Carnegie Mellon University, Pittsburgh, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Teodora Nicola

    Department of Pediatrics, Division of Neonatology, University of Alabama at Birmingham, Birmingham, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Celia Espinoza

    Department of Pediatrics, Division of Respiratory Medicine, University of California, San Diego, La Jolla, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Divya Chhabra

    Department of Pediatrics, Division of Respiratory Medicine, University of California, San Diego, La Jolla, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. James S Hagood

    Department of Pediatrics, Division of Respiratory Medicine, University of California, San Diego, La Jolla, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Naftali Kaminski

    Section of Pulmonary, Critical Care and Sleep Medicine, School of Medicine, Yale University, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Namasivayam Ambalavanan

    Department of Pediatrics, Division of Neonatology, University of Alabama at Birmingham, Birgmingham, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Ziv Bar-Joseph

    Machine Learning and Computational Biology, School of Computer Science, Carnegie Mellon University, Pittsburgh, United States
    For correspondence
    zivbj@cs.cmu.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3430-6051

Funding

National Institutes of Health (U01 HL122626)

  • Ziv Bar-Joseph

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Anshul Kundaje

Ethics

Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols (APN 10042) of the University of Alabama at Birmingham. All lungs were isolated immediately following euthanasia using approved protocols.

Version history

  1. Received: June 6, 2016
  2. Accepted: January 23, 2017
  3. Accepted Manuscript published: January 26, 2017 (version 1)
  4. Version of Record published: February 21, 2017 (version 2)

Copyright

© 2017, Kleyman et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,495
    Page views
  • 494
    Downloads
  • 21
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Michael Kleyman
  2. Emre Sefer
  3. Teodora Nicola
  4. Celia Espinoza
  5. Divya Chhabra
  6. James S Hagood
  7. Naftali Kaminski
  8. Namasivayam Ambalavanan
  9. Ziv Bar-Joseph
(2017)
Selecting the most appropriate time points to profile in high-throughput studies
eLife 6:e18541.
https://doi.org/10.7554/eLife.18541

Share this article

https://doi.org/10.7554/eLife.18541

Further reading

    1. Cell Biology
    2. Computational and Systems Biology
    Thomas Grandits, Christoph M Augustin ... Alexander Jung
    Research Article

    Computer models of the human ventricular cardiomyocyte action potential (AP) have reached a level of detail and maturity that has led to an increasing number of applications in the pharmaceutical sector. However, interfacing the models with experimental data can become a significant computational burden. To mitigate the computational burden, the present study introduces a neural network (NN) that emulates the AP for given maximum conductances of selected ion channels, pumps, and exchangers. Its applicability in pharmacological studies was tested on synthetic and experimental data. The NN emulator potentially enables massive speed-ups compared to regular simulations and the forward problem (find drugged AP for pharmacological parameters defined as scaling factors of control maximum conductances) on synthetic data could be solved with average root-mean-square errors (RMSE) of 0.47 mV in normal APs and of 14.5 mV in abnormal APs exhibiting early afterdepolarizations (72.5% of the emulated APs were alining with the abnormality, and the substantial majority of the remaining APs demonstrated pronounced proximity). This demonstrates not only very fast and mostly very accurate AP emulations but also the capability of accounting for discontinuities, a major advantage over existing emulation strategies. Furthermore, the inverse problem (find pharmacological parameters for control and drugged APs through optimization) on synthetic data could be solved with high accuracy shown by a maximum RMSE of 0.22 in the estimated pharmacological parameters. However, notable mismatches were observed between pharmacological parameters estimated from experimental data and distributions obtained from the Comprehensive in vitro Proarrhythmia Assay initiative. This reveals larger inaccuracies which can be attributed particularly to the fact that small tissue preparations were studied while the emulator was trained on single cardiomyocyte data. Overall, our study highlights the potential of NN emulators as powerful tool for an increased efficiency in future quantitative systems pharmacology studies.

    1. Computational and Systems Biology
    2. Neuroscience
    Domingos Leite de Castro, Miguel Aroso ... Paulo Aguiar
    Research Article Updated

    Closed-loop neuronal stimulation has a strong therapeutic potential for neurological disorders such as Parkinson’s disease. However, at the moment, standard stimulation protocols rely on continuous open-loop stimulation and the design of adaptive controllers is an active field of research. Delayed feedback control (DFC), a popular method used to control chaotic systems, has been proposed as a closed-loop technique for desynchronisation of neuronal populations but, so far, was only tested in computational studies. We implement DFC for the first time in neuronal populations and access its efficacy in disrupting unwanted neuronal oscillations. To analyse in detail the performance of this activity control algorithm, we used specialised in vitro platforms with high spatiotemporal monitoring/stimulating capabilities. We show that the conventional DFC in fact worsens the neuronal population oscillatory behaviour, which was never reported before. Conversely, we present an improved control algorithm, adaptive DFC (aDFC), which monitors the ongoing oscillation periodicity and self-tunes accordingly. aDFC effectively disrupts collective neuronal oscillations restoring a more physiological state. Overall, these results support aDFC as a better candidate for therapeutic closed-loop brain stimulation.